TENOFOVIR ALAFENAMIDE for Hepatitis d: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where TENOFOVIR ALAFENAMIDE was used for Hepatitis d.
Most Reported Side Effects for TENOFOVIR ALAFENAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 217 | 7.3% | 214 | 2 |
| Product dose omission issue | 153 | 5.1% | 4 | 18 |
| Off label use | 96 | 3.2% | 8 | 31 |
| Drug ineffective | 93 | 3.1% | 5 | 13 |
| Fatigue | 92 | 3.1% | 1 | 8 |
| Headache | 71 | 2.4% | 0 | 6 |
| Product dose omission | 69 | 2.3% | 0 | 2 |
| Intentional dose omission | 67 | 2.2% | 0 | 5 |
| Product use issue | 67 | 2.2% | 0 | 6 |
| Nausea | 64 | 2.1% | 1 | 7 |
| Diarrhoea | 60 | 2.0% | 4 | 21 |
| Maternal exposure during pregnancy | 58 | 1.9% | 0 | 4 |
| Foetal exposure during pregnancy | 52 | 1.7% | 7 | 9 |
| Neoplasm malignant | 52 | 1.7% | 9 | 11 |
| Hepatitis b | 48 | 1.6% | 3 | 16 |
Other Indications for TENOFOVIR ALAFENAMIDE
Hepatitis b (935)
Product used for unknown indication (757)
Chronic hepatitis b (679)
Hiv infection (197)
Hepatitis viral (38)
Acute hepatitis b (36)
Antiretroviral therapy (24)
Hepatic cirrhosis (23)
Hepatitis b reactivation (21)
Acquired immunodeficiency syndrome (15)
Other Drugs Used for Hepatitis d
BULEVIRTIDE (42)
PEGINTERFERON ALFA-2A (37)
TENOFOVIR DISOPROXIL (24)
ENTECAVIR (5)
LAMIVUDINE (5)
PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B (5)
TENOFOVIR (5)